Carregant...
LOW GLUCOSE ENHANCES METFORMIN PROTECTION EFFICIENCY AGAINST DOXORUBICIN INDUCED CYTOTOXICITY
The anti-diabetic drug, metformin, has been reported to benefit the cardiovascular system and may facilitate extension of healthy lifespan. Doxorubicin (doxo) is a leading chemotherapeutic drug used to treat a variety of cancers, but it has cardiotoxic effects that limit its clinical benefit. To tes...
Guardat en:
| Publicat a: | Innov Aging |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6239411/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/geroni/igy031.3300 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|